GlassScriptPhysician profile
Steven Daniels
NPI 1487650008
$1,891.34
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $113 · 2021: $387 · 2022: $220 · 2023: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $378.38 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $190.42 | 2021-2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.55 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $137.98 | 2019-2021 | |
| Boston Scientific Corporation | $128.49 | 2019-2023 | Watchman Access System |
| Abiomed | $110.85 | 2019 | |
| Cardiovascular Systems INC. | $101.64 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.48 | 2019-2023 | Lifevest |
| Pfizer INC. | $92.82 | 2022-2023 | |
| Cvrx, INC. | $86.25 | 2021-2023 | Barostim Neo System |
| Amarin Pharma, INC. | $74.20 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $58.14 | 2019 | |
| Amgen INC. | $35.40 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.27 | 2021 | |
| Biotronik INC. | $32.25 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $26.12 | 2023 | Optimizer |
| Itamar Medical INC | $23.43 | 2023 | Watchpatone |
| Ironshore Pharmaceuticals INC. | $20.34 | 2022 | |
| Esperion Therapeutics, INC. | $19.31 | 2021 | |
| Genentech USA, INC. | $18.39 | 2020 | |
| Lundbeck LLC | $18.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.04 | 2022 | |
| Avinger INC. | $13.71 | 2021 | |
| Cook Medical LLC | $12.78 | 2023 | Evolution |
| Astrazeneca Pharmaceuticals LP | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.